Wound Care Specialist Opening New Office at Harlingen Medical Center to Treat Diabetes, Other Patients with Foot Problems

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

HARLINGEN –  Dr. Luis R. Venegas, DPM, ABPM, a podiatrist, is opening a new office in Harlingen to treat patients with foot problems – including many diabetes patients in the Valley who may develop wounds on their feet which are difficult to heal.  At his new office, located at Harlingen Medical Center’s Medical Office Building, Dr. Venegas will look to increase access to foot care for patients in the Harlingen-San Benito area, and surrounding communities. 

Dr. Venegas has been seeing patients at the Wound Healing Center at Harlingen Medical Center for more than seven years now – as well as treating patients in the Brownsville area for the past 17 years.  During recent years, Dr. Venegas said he has been seeing more young patients in the Valley, including some in their 30’s and 40’s, developing foot wounds related to diabetes.  Dr. Venegas said that diabetic patients should check their feet every day, to look for lesions, ulcers or any other problems, which could lead to damage and dangerous infections of their feet. 

The public is invited to see Dr. Venegas’ new office and the Wound Healing Center during an open house on Wednesday, April 13, 2016, anytime between 3:30 p.m. and 5:30 p.m., in Harlingen Medical Center’s Medical Office Building, located at 5005 S. Expressway 77, Suite 101 and Suite 100 (in the building closest to the Expressway, outside the hospital, on the first floor).

- Advertisement -

In addition, the community can learn more about wound healing and ask questions to Dr. Venegas during a free “Doc Talk” that same evening, April 13, at 6 p.m. in Harlingen Medical Center’s conference room (also located in the HMC Medical Office Building, on the first floor, behind the elevators).  This event is being held as part of “National Foot Health Awareness Month” during the month of April. 

To RSVP for Dr. Venegas’ talk, which will include refreshments, please call (956) 365-1848.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -